Navigation Links
Blutkrankheiten: Zehntausend europäische Hämatologen versammeln sich vom13.-16. Juni 2013 in Stockholm
Date:5/13/2013

DEN HAAG, Niederlande, May 13, 2013 /PRNewswire/ --

- Einladung zum 18. Kongress des europäischen Hämatologenverbandes EHA (European Hematology Association)

Der Vorstand des europäischen Hämatologenverbandes EHA (European Hematology Association) lädt Sie herzlich ein, als Pressevertreter am 18. EHA-Kongress teilzunehmen.

Informationen zum jährlichen EHA-Kongress

Das Fachgebiet Hämatologie befasst sich mit allen Themen rund um unser Blut: seine Entstehung im Knochenmark, Erkrankungen des Blutes und ihre Behandlung. Hier werden aktuelle Daten aus der hämatologischen Forschung und Entwicklung präsentiert. Zielgruppe des Kongresses sind Gesundheitsexperten, die sich auf das Gebiet der Hämatologie spezialisiert haben. Die wissenschaftlichen Themen decken ein breites Spektrum von der Physiologie und Entwicklung von Stammzellen über Leukämie, Lymphome, Myelome und deren Diagnose und Behandlung, Erkrankungen der roten und weißen Blutkörperchen sowie der Blutplättchen, Thrombosen und Blutgerinnungsstörungen wie der Hämophilie bis hin zu Bluttransfusionen und Stammzellentransplantationen ab.

Pressegespräch: Freitag, 14. Juni 2013 von 08:30 - 10:00 Uhr MEZ.

Das Pressegespräch findet in Halle C5 des Stockholmsmässan statt.

Zu den Themen gehören:

  • Durchbrüche beim Verständnis der Biologie von Leukämie im Kindesalter
  • Neue Behandlungsansätze für Lymphome/Leukämie mit kleinen Molekülen
  • Alter und Alterung bei Blutkrankheiten
  • Durchbrüche bei der Behandlung multipler Myelome und chronischer lymphatischer Leukämie
  • Neue Maßnahmen zur Vermeidung von Eisenüberladung
  • Neue Einblicke in die Biologie und Behan
    '/>"/>

SOURCE European Hematology Association
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Blutkrankheiten: Europäische Hämatologen kommen vom 13. bis zum 16. Juni 2013 in Stockholm zusammen
2. Maladies du sang : congrès des hématologues européens à Stockholm, du 13 au 16 juin 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... The fully automated supercritical fluidic chromatography-based ... analyze up to 48 samples utilizing automatic extraction ... targets by mass spectrometry. , The Nexera ... requirements of a wide range of applications, including ... search for disease biomarkers, additives in forming polymers, ...
(Date:2/27/2015)... South San Francisco, CA (PRWEB) February 27, 2015 ... it is joining forces on February 28 with patients ... globally to raise awareness for Rare Disease Day®. ... of rare diseases and calling attention to the special ... support community around them. , “Cytokinetics is proud to ...
(Date:2/26/2015)... -- On behalf of biotech client GenScript USA, ... & Spitzer, P.A. (Wilentz) secured a significant jury verdict ... excess of $10 million. The jury determined that Genewiz ... it improperly hired one or more of GenScript,s employees.  ... notwithstanding the verdict, a new trial, and remittitur. ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015   Regulus ... biopharmaceutical company leading the discovery and development of innovative ... Xanthopoulos , Ph.D., President and Chief Executive Officer of ... and Company 35 th Annual Healthcare Conference on ... conference is being held at the Boston Marriott Copley ...
Breaking Biology Technology:Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3
... Inc. (Nasdaq: HGSI ) announced today that ... Healthcare Conference will be webcast,and may be accessed ... ), A member of Human Genome ... on Thursday, September 4, 2008 at 8:35 am ...
... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) ... Administration (FDA) review, the Company is initiating ... administration of REOLYSIN(R) in,combination with paclitaxel and ... (NSCLC) with K-RAS or EGFR-activated tumours. The ...
... 2 /PRNewswire-FirstCall/ - OncoGenex,Pharmaceuticals, Inc. (NASDAQ: ... today that it has granted to Eagle ... and commercialize TOCOSOL(R),Paclitaxel. Under the terms of ... payments from future TOCOSOL Paclitaxel sales and ...
Cached Biology Technology:/R E P E A T -- Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours/ 2/R E P E A T -- Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours/ 3/R E P E A T -- Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours/ 4OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals 2OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals 3
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62/113114 for DISTRIBUTED METHOD AND ... The patent further establishes NXT-ID,s position in the ... property portfolio the ability for multiple devices to collaborate ...
(Date:2/5/2015)... PARK, North Carolina , 5. Februar ... 35. Jahr als spezialisiertes Logistikunternehmen und hat ... als einzige klinische Logistikfirma (Clinical Logistics Organization ... Kernbotschaft der neuen Kampagne lautet First ... Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... 27, 2015   Marvin Test Solutions ... innovative test solutions for military, aerospace, and ... its TS-323 GENASYS Test Platform ... GENASYS is a high-performance PXI-based system designed ... that require performance functional testing. GENASYS features ...
Breaking Biology News(10 mins):NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
... In recent years, the possible applications for double-walled ... those working on developing renewable energy technologies. These ... thin enough to be transparent, yet can still ... advanced solar panels, sensors and a host of ...
... for Glycomics in collaboration with colleagues at the ... to identifying a broad spectrum treatment for the ... These highly-infectious viruses are the leading cause of ... of hospitalisations in the developed world, and hundreds ...
... Dec. 23, 2008 -- The reproductive spores of many ... to new research by mycologists and applied mathematicians at ... this week in the Proceedings of the National ... fungal spores is within one percent of the absolute ...
Cached Biology News:Researchers find chink in the armor of viral 'tummy bug' 2In many fungi, reproductive spores are remarkably aerodynamic 2
... used technique for studying protein function and ... SDS-PAGE and transferred to a membrane such ... probed with specific antibodies. Unlike nucleic acid ... and Northern blots, it has been difficult ...
... Basic Package Superior Protein Detection and ... ProXPRESS 2D Proteomic Imaging System is a ... proteomic and general life science research applications. ... use of all dyes in the UV ...
... Introducing our Regulatory Edition of Molecular Imaging ... systems for life science research and drug ... compliance with U.S. Food and Drug Administrations ... 11 Electronic Records; Electronic Signatures [21 CFR ...
... is a 16 amino acid (amino acids 3-18) synthetic peptide ... The sequence of this peptide is (amino to carboxy terminus): ... V - K - L - R - A - ... K(18). This peptide may be used for neutralization ...
Biology Products: